Simulations Plus (SLP) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for Simulations Plus
Is Simulations Plus a buy right now? The alternative data leans yes. This SLP stock analysis is built on the 25+ alternative data signals AltIndex tracks on Simulations Plus every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 69/100: a Buy. The stock trades at $18.43 with a $373M market cap.
What’s driving the buy signal over the past 90 days: web traffic up 58.4% to 35K monthly visits, 87% of employees are positive on the business outlook, and headcount (according to LinkedIn) up 8.2% to 210 employees. Stocks scoring above 60 have historically outperformed the S&P 500 over the following six months.
SLP’s broader alt-data profile also covers job postings (7 open roles), quarterly revenue ($20M), X followers (918), and sentiment (100/100). Every signal links to its own page with full history, the SLP technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on SLP is just below.
Simulations Plus AI Stock Analysis
Simulations Plus, Inc. (SLP) is a leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries. The company’s products are used by researchers and scientists worldwide to predict how drugs behave in the human body, aiding in the development of new therapies.
Analysis generated September 1, 2026.
Recent Simulations Plus Stock Alerts
![]() |
Simulations Plus | August 10 Employee Rating is up by 4.7% over the last month. |
![]() |
Simulations Plus | August 10 Business Outlook among employees is up by 8.8% over the last month. |
![]() |
Simulations Plus | August 6 Insider Alert: DiBella John Anthony II is selling shares |
![]() |
Simulations Plus | July 14 Employee Rating is down by 4.4% over the last month. |
Simulations Plus Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 35K | 58.4% | |
| Job Posts | 7 | 0% | |
| LinkedIn Employees | 210 | 8.2% | |
| Wikipedia Views | 3 | 0% | |
| Employee Recommend | 91 | 3.2% | |
| Business Outlook | 87 | 8.8% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 7 | N/A | |
| Stocktwits Mentions | 0 | N/A | |
| News Mentions | 0 | 100.0% | |
| Stocktwits Subscribers | 1K | 1.4% | |
| X Followers | 918 | 0% | |
| Facebook Followers | 549 | 0.7% | |
| Facebook Engagement | 9 | 62.5% |
About Simulations Plus (SLP)
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
| Price | $18.43 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $373M |
| Year Range | $11 – $21 |
| Dividend Yield | 0% |
| PE Ratio | 46.1 |
| Analyst Rating | 38% buy |
| Industry | Digital health |
Latest Simulations Plus News
View more →
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting DisclosuresAugust 6 - GlobeNewswire |
|
![]() |
Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?July 31 - PRNewswire |
![]() |
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASGJuly 23 - PRNewswire |
Halper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their ShareholdersJuly 10 - GlobeNewswire |
See Simulations Plus’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for SLP, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREESimulations Plus Earnings & Financial Performance
View all earnings →Simulations Plus Insider Trading Activity
View all →| DiBella John Anthony II filed to sell 85,140 shares at $0.0. Aug 3 '26 |
| DiBella John Anthony II filed to sell 86,140 shares at $0.0. Jul 6 '26 |
| WOLTOSZ WALTER S filed to sell 3,202,131 shares at $0.0. Jul 1 '26 |
| Fiedler-Kelly Jill filed to sell 77,817 shares at $0.0. Jun 16 '26 |
| Fiedler-Kelly Jill filed to sell 77,817 shares at $0.0. Jun 15 '26 |
Simulations Plus Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Simulations Plus
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
![]() |
TruBridgeTBRG |
$26.24 0.0% | $394M | 45 |
![]() |
AmwellAMWL |
$13.48 3.8% | $221M | 27 |
![]() |
ForianFORA |
$2.17 0.5% | $68M | 59 |
![]() |
OneMedNetONMD |
$0.69 1.4% | $40M | 55 |
![]() |
MangoceuticalsMGRX |
$0.42 1.0% | $9M | 42 |
Explore Simulations Plus Data
Frequently Asked Questions: Simulations Plus (SLP)
Simulations Plus has an AltIndex AI Score of 69/100 (Buy). The score reflects positive alternative data signals. All investments carry risk.
69/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Simulations Plus (SLP) stock is $18.43 with a market cap of $373M.
As of today, Simulations Plus’s PE (Price to Earnings) ratio is 46.1.
View the latest Simulations Plus insider transactions to see recent buying and selling activity by company executives and directors.
Check the Simulations Plus congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The SLP stock price chart above shows Simulations Plus’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Simulations Plus technical analysis for RSI, moving averages, and more.
See the stocks similar to Simulations Plus section on this page for companies in the same industry ranked by market cap and AI Score.






